Product Description
Tucatinib is an oral prescription medication used as a targeted therapy to treat advanced HER2-positive breast cancer and specific types of colorectal cancer.
- Standard Dose: 300 mg taken orally twice a day (usually two 150 mg tablets in the morning and two at night).
- Timing: Space doses about 12 hours apart, taken with or without food.
- Handling: Swallow tablets whole. Do not crush, chew, or break them.